Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 80.50
+0.50 (0.63%)
Mar 18, 2026, 5:35 PM CET
BME:ROVI Revenue
In the year 2025, Laboratorios Farmaceuticos Rovi had annual revenue of 743.48M EUR, down -2.65%. Laboratorios Farmaceuticos Rovi had revenue of 218.42M in the quarter ending December 31, 2025, with 9.68% growth.
Revenue
743.48M
Revenue Growth
-2.65%
P/S Ratio
5.50
Revenue / Employee
372.11K
Employees
2,045
Market Cap
4.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 743.48M | -20.27M | -2.65% |
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Almirall | 1.11B |
| Faes Farma | 626.99M |
| Laboratorio Reig Jofre | 336.68M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 221.39M |
Laboratorios Farmaceuticos Rovi News
- 19 days ago - Laboratorios Farmaceuticos Rovi SA (STU:41L) Q4 2025 Earnings Call Highlights: Strategic Growth ... - GuruFocus
- 19 days ago - Q4 2025 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript - GuruFocus
- 1 year ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus